AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Nov 17, 2018
30071_dirs_2018-11-16_233efc89-ba94-4518-be00-5de04cb0c14d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-11-14
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-11-15 | ResMed Common Stock | S | 2000 | $101.44 | Disposed | 72156 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-11-14 | ResMed Common Stock Options | $101.64 | A | 22883 | Acquired | 2025-11-14 | ResMed Common Stock (22883) | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 Plan.
F2: Includes 134.30 shares of ResMed stock purchased on October 31, 2018, through the ResMed Employee Stock Purchase Plan.
F3: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2019, 2020 and 2021.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29